Welcome - CNS - Validated tests an QA
Founded in 1996 - CNS focus - Validated tests - Quality - Customers - Publications
Therapeutic area - Methods - Disease Models - Programs - Research Collaboration Contract Research - Research Partner - Research Collaboration - QA Program - Confidentiality and IP Rights Sign-up for mailing list - Examples of newsletters Contact us
Search engine
PRECLINICAL RESEARCH
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE)
in Lewis rat
PDF file
Introduction
Compound testing
EAE is a commonly used animal model which shares some degree of similarities with human multiple sclerosis (MS).
EAE is induced by CNS antigens such myelin basic protein (MBP) which activates autoreactive T-cells responsible for CNS inflammation and demyelination. Within 10 days after the immunization with MBP of susceptible Lewis rats they develop a progressive weight loss and paralysis that can be assessed using semi-quantitative neurological scoring system (0 = no abnormality; 1 = distal weakness of the tail; 2 = complete weakness of the tail; 3 = mild weakness in one or two hindlimbs; 4 = moderate paraparesia of one or two hindlimbs; 5 = total paraplegia).
Compound testing addresses the effect of subchronic or chronic treatment of rats (typically starting the before the appearance of first symptom) on:

- neurological score until complete recovery

- body weight



Dexamethsone treatment administrated from day 8 to 12 improves the clinical score of EAE rats.
Body weight loss during the course of EAE